NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bioliberty

Bioliberty

Private
EdinburghHealthcare & Life Scienceshttps://www.bioliberty.com/

Last Round

Series A

Mar 18, 2026

Total Funding Raised

$5.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Bioliberty is a medical technology company that develops soft robotic wearables and a digital therapy platform to assist with patient recovery from mobility-limiting conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

robotic rehabilitationassistive glovestroke recoverysoft roboticsrehab techmedical devicehand therapyexoskeleton glovegamified rehabilitationrehabilitation platformhealth IoTpatient monitoringwearable roboticsSaaSFDA-registered

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bioliberty Comps

Public and private peers based on sector, stage, and business model.

Bioliberty comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bioliberty Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 18, 2026
Pre SeedJul 1, 2025
GrantDec 4, 2023
SeedApr 4, 2023
GrantDec 8, 2022

Key People

Founding team and executive leadership

Conan Bradley

Co-Founder And Chief Commercial Officer

Founding Team

Ross O'Hanlon

Co-Founder CTO

Founding Team

Shea Quinn

Co-Founder Chief Operating Officer

Founding Team

Barry Hextall

Chief Financial Officer

Executive Team

Bioliberty Investors

Notable investors and investment history

Bioliberty investors
InvestorRounds
Innovate UKGrant
Scottish EDGEGrant
Innovate UKGrant
Old College CapitalPre Seed, Seed, Series A
Scottish National Investment BankSeries A
Archangel InvestorsPre Seed, Series A, Seed
Eos AdvisoryPre Seed, Seed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 19, 2026

    $8.27M round completed.

  • Oct 1, 2025

    Core technologies Lifehub and Lifeglov are FDA-registered.

Bioliberty Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bioliberty Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bioliberty's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh
Employee Range32
Year Founded2020
Last FundingMar 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.